# Cygnos Biotech, LLC

Canonical: https://abierto.us/vendors/cygnos-biotech-llc-pxydy5cqjdm3

- UEI: PXYDY5CQJDM3
- CAGE: 8WQ76
- Location: Miami, FL
- Awards in window: 2 (4 transactions), $1,601,657 obligated, March 4, 2025 to May 15, 2026

## Awarding agencies

- Department of the Army: 2 awards, $1,601,657

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $1,601,657

## Competition

- Full and Open Competition After Exclusion of Sources: 2 awards

## Largest awards

- W911SR26CA003 (definitive contract): $1,397,164, W6QK ACC-APG. The Purpose of This Small Business Innovation Research (Sbir) Phase II Contract Is to Show Efficacy of Anti-Viral Treatment with the PVX Therapeutic.. https://www.usaspending.gov/award/CONT_AWD_W911SR26CA003_9700_-NONE-_-NONE-/
- W911SR25C0013 (definitive contract): $204,493, W6QK ACC-APG. Research to Create a Class of Agnostic Drugs Targeting the Host to Assist in Fighting Off a Broad Spectrum of Viral Pathogens.. https://www.usaspending.gov/award/CONT_AWD_W911SR25C0013_9700_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/cygnos-biotech-llc-pxydy5cqjdm3.